Research

Study on roots of asthma hints at potential of ‘birth cohort’ project

Tue May 19, 2020

Sam Oh, PhD, MPH

By studying the health of Puerto Ricans from birth, researchers hope to discover more about causes of asthma.

In clinical work and discovery science, the School takes on COVID-19

Tue May 12, 2020

Human cells infected with SARS-CoV-2 virus

NIAID/NIH

The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.

Update from the Dean: Eyeing a return

Fri May 8, 2020

Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: Dean Guglielmo provides an update on School activities and a careful return to campus

Respiratory infections may drive Puerto Rico’s high asthma burden

Thu May 7, 2020

UCSF team has discovered drugs that block coronavirus, paving way for ‘a better drug sooner’

Thu May 7, 2020

Oni-Orisan given the Darrell Abernethy Early Stage Investigator Award

Thu Apr 30, 2020

Akinyemi Oni-Orisan, PharmD, PhD

Oni-Orisan was recognized for his contributions to clinical pharmacology.

Overcoming disease with moving pictures and molecular building blocks

Mon Apr 13, 2020

Elisabeth Fall

Jaime Fraser, PhD

Jaime Fraser delivered the 2020 Byers Award Lecture in Basic Science

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

Thu Apr 2, 2020

Susan Merrell

Nadav Ahituv, PhD, right, with postdoctoral scholar Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school—for the 40th consecutive year.

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020

SARS-COV2 virus particles on human cells

NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue).

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020

QBI’s director, Nevan Krogan, PhD, left, and Jacqueline Fabius, QBI's chief operating officer

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

Categories: Research